Clinical trial
A Phase 3, Single-Arm, Open-Label, Long-Term Extension Study To Evaluate The Safety And Efficacy Of Enpatoran In Participants With Active Cutaneous Manifestations Of Lupus Erythematosus With Or Without Systemic Disease Receiving Standard Of Care [Elowen-LTE]
NCT07840287 is registered in ClinicalTrials.gov with EMD Serono Research & Development Institute, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3, Single-Arm, Open-Label, Long-Term Extension Study To Evaluate The Safety And Efficacy Of Enpatoran In Participants With Active Cutaneous Manifestations Of Lupus Erythematosus With Or Without Systemic Disease Receiving Standard Of Care [Elowen-LTE]
- Lead sponsor
- EMD Serono Research & Development Institute, Inc.
- Phase
- Phase 3
- Overall status
- Not yet recruiting
- Start date
- October 15, 2026
- Completion date
- September 1, 2031
- Enrollment
- 404 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous lupus erythematosus (cle), systemic lupus erythematosus (sle)